Brief: Amplitude Surgical H1 EBITDA Down At 9.9 Million Euros

Amplitude Surgical SA

23/03/2022 17:08

March 23 (Reuters) - Amplitude Surgical SA  AMPLI.PA :
    * AMPLITUDE SURGICAL ANNOUNCES ITS RESULTS FOR THE FIRST
HALF OF
2021-22
    * H1 OPERATING PROFIT 1.6 MILLION EUR VERSUS 1.2 MILLION EUR
YEAR
AGO
    * H1 CONSOLIDATED SALES OF EUR 48.1 MILLION, +3.9% AT
CONSTANT
EXCHANGE RATES
    * H1 EBITDA DOWN 9.0% TO EUR 9.9 MILLION WITH A MARGIN OF
20.5%
    * H1 RECURRING OPERATING PROFIT OF EUR 1.9 MILLION
    * END-DECEMBER 2021 CASH AND CASH EQUIVALENTS OF EUR 24.6
MILLION
    * GROUP HAS NO COMMERCIAL EXPOSURE IN UKRAINE OR RUSSIA
    * ITS RUSSIA EXPOSURE IS LIMITED TO CHANGES IN ENERGY COSTS
AND
PRICE OF RAW MATERIALS, NOTABLY TITANIUM, THAT IMPACT PRODUCT
MANUFACTURING COSTS
    * IMPROVEMENT OF SANITARY SITUATION IN FRANCE SINCE FEBRUARY
HAS
ALLOWED SINCE BEGINNING OF MARCH, A RETURN OF MARKET CLOSER TO
NORMAL

Source text for Eikon:  ID:nBw2vvwq1a 
Further company coverage:  AMPLI.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))